You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 10,799,642


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,799,642
Title:Dose guides for injection syringe
Abstract: The present embodiments provide for simple devices that guide the loading and dispensing of accurate small doses of fluid from standard injection syringes.
Inventor(s): Wong; Vernon G. (Menlo Park, CA), Pham; Tan (San Jose, CA), White; William S. (Birmingham, AL), Huang; Glenn T. (Fremont, CA), Hu; Mae W. (Los Altos Hills, CA)
Assignee: ICON BIOSCIENCE, INC. (Watertown, MA)
Application Number:16/012,497
Patent Claim Types:
see list of patent claims
Use; Composition; Compound; Delivery; Device;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 10,799,642: A Detailed Analysis

Introduction

The United States Patent 10,799,642, titled "Dose guides for injection syringe," is a significant innovation in the medical field, particularly in the administration of precise doses of fluid from standard injection syringes. This article delves into the scope, claims, and the broader patent landscape surrounding this invention.

Background of the Patent

The patent, filed as US16/012,497, was granted on October 6, 2020. It addresses a critical need in medical practice: the accurate loading and dispensing of small doses of fluid from injection syringes. This invention is designed to enhance precision and safety in medical procedures[4].

Scope of the Patent

Problem Statement

The administration of precise doses of medication is a challenging task, especially when using standard injection syringes. The lack of precision can lead to dosing errors, which can have serious consequences for patients.

Solution Provided

The patent describes a simple yet effective device that guides the loading and dispensing of accurate small doses of fluid. This device ensures that the dose administered is precise, reducing the risk of errors. The invention includes a dose guide that can be attached to the syringe, providing clear markings and a mechanism to control the plunger rod, thereby ensuring accurate dosing[4].

Claims of the Patent

Independent Claims

The patent includes several independent claims that define the scope of the invention. These claims are crucial as they outline what is protected under the patent.

  • Claim 1: This claim describes the overall device, including the dose guide and its attachment to the syringe. It specifies the mechanism for controlling the plunger rod to achieve precise dosing.
  • Claim 2: This claim focuses on the design of the dose guide, including the markings and the structure that interacts with the plunger rod.
  • Claim 3: This claim details the method of using the device, emphasizing the steps involved in loading and dispensing the precise dose[4].

Dependent Claims

Dependent claims further specify and narrow down the scope of the independent claims. These claims often describe variations or additional features of the invention.

  • Claim 4: This claim describes a specific embodiment of the dose guide with additional features such as adjustable markings.
  • Claim 5: This claim outlines a method for manufacturing the dose guide, ensuring consistency and precision in production[4].

Patent Landscape

Technology Area

The patent falls under the medical devices category, specifically within the field of injection syringes and dosing systems. This area has seen significant innovation in recent years, driven by the need for precision and safety in medical procedures.

Comparative Analysis

  • Patent Activity: The USPTO has seen a significant increase in patents related to medical devices, particularly in areas involving precision and safety. For instance, patents in the technology area of "instruments" have been on the rise, reflecting the broader trend of innovation in medical technology[1].
  • Global Trends: Globally, there is a growing focus on improving medical device technology. Patents in this area are often characterized by their specificity and the need for clear, precise claims to avoid ambiguity and ensure patent validity[1].

Metrics for Measuring Patent Scope

Independent Claim Length and Count

Research has shown that the scope of a patent can be measured using metrics such as independent claim length and independent claim count. Narrower claims, as seen in this patent, are often associated with a higher probability of grant and a shorter examination process. This suggests that the claims in US 10,799,642 are well-defined and specific, contributing to the patent's validity and enforceability[3].

Legal Considerations

Claim Indefiniteness

The clarity and definiteness of patent claims are critical legal considerations. The Federal Circuit has emphasized that patent claims must be precise enough to afford clear notice of what is claimed, thereby informing the public of what is still open to them. The claims in US 10,799,642 are detailed and specific, aligning with the legal standards for claim definiteness[2].

Practical Implications

Impact on Medical Practice

The invention described in US 10,799,642 has the potential to significantly improve medical practice by reducing dosing errors. This can lead to better patient outcomes and increased confidence in the administration of medications.

Economic Impact

The precision and safety offered by this invention can also have economic benefits. By reducing errors, healthcare providers can minimize the costs associated with incorrect dosing, such as additional treatments or legal liabilities.

Future Directions

Small Claims Patent Court

The discussion around a small claims patent court, as studied by the Administrative Conference of the United States (ACUS), could impact the enforcement and litigation of patents like US 10,799,642. A small claims court could provide a more accessible and cost-effective way for inventors to protect their rights, especially for smaller entities or individual inventors[5].

Key Takeaways

  • Precision in Dosing: The patent US 10,799,642 addresses a critical need for precise dosing in medical procedures.
  • Clear Claims: The claims are specific and well-defined, ensuring clarity and validity.
  • Broader Impact: The invention has significant practical and economic implications for medical practice.
  • Legal Considerations: The patent aligns with legal standards for claim definiteness and scope.

FAQs

What is the main purpose of the invention described in US 10,799,642?

The main purpose is to provide a device that guides the loading and dispensing of accurate small doses of fluid from standard injection syringes.

How does the patent ensure precision in dosing?

The patent describes a dose guide with clear markings and a mechanism to control the plunger rod, ensuring that the dose administered is precise.

What are the key claims of the patent?

The key claims include the overall device, the design of the dose guide, and the method of using the device to achieve precise dosing.

How does this patent fit into the broader patent landscape?

The patent falls within the medical devices category, reflecting a broader trend of innovation in medical technology focused on precision and safety.

What are the potential economic benefits of this invention?

The invention can reduce the costs associated with incorrect dosing, such as additional treatments or legal liabilities, and improve patient outcomes.

Cited Sources

  1. Invention: U.S. and Comparative Global Trends - National Science Foundation.
  2. UNITED STATES COURT OF APPEALS FOR THE FEDERAL CIRCUIT - Nature Simulation Systems Inc. v. Autodesk, Inc.
  3. Patent Claims and Patent Scope - SSRN.
  4. US10799642B2 - Dose guides for injection syringe - Google Patents.
  5. U.S. Patent Small Claims Court - Administrative Conference of the United States.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,799,642

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Eyepoint Pharms DEXYCU KIT dexamethasone SUSPENSION;INTRAOCULAR 208912-001 Feb 9, 2018 RX Yes Yes 10,799,642 ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,799,642

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2012249757 ⤷  Subscribe
Brazil 112013027428 ⤷  Subscribe
Canada 2833570 ⤷  Subscribe
China 103648544 ⤷  Subscribe
Cyprus 1122054 ⤷  Subscribe
Denmark 2701773 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.